The document summarizes recent updates made to the proposed revisions for the DSM-5. It lists changes made to diagnostic criteria and organizational structure across several disorder categories. Stakeholders are invited to provide feedback on the changes between now and June 15, 2011, at which point a third round of revisions will be made followed by another opportunity for comments. The page will then be updated to highlight areas that have changed.
DSM - Diagnostic and Statistical Manual of Mental Disorders,
It is the handbook used by health care professionals as an authoritative guide to the diagnosis of mental disorders.
The DSM-5: Overview of Main Themes and Diagnostic RevisionsJames Tobin, Ph.D.
DSM-5 represents the field’s most recent attempt at revising the DSM-IV-TR diagnostic nomenclature. In this presentation, I will outline the primary efforts of the DSM-5 Task Force and the major diagnostic changes that were incorporated in the new manual, with an emphasis on the disorders of adulthood. The most promising changes are the organization of mental illness as a spectrum, the addition of dimensionality to specifier descriptions, lifespan/development and cultural refinements, and the articulation of a new hybrid model of mental illness. In the context of these gains, I also will provide a summary of the major controversies surrounding the DSM-5, including misgivings about lower thresholds to qualify for numerous diagnoses and the related concern that we may now run the risk of pathologizing “normal” human functioning.
Core slides from my presentation about the new DSM diagnostic system. The full presentation has more zing but I removed some to streamline and to whet the appetite.
DSM - Diagnostic and Statistical Manual of Mental Disorders,
It is the handbook used by health care professionals as an authoritative guide to the diagnosis of mental disorders.
The DSM-5: Overview of Main Themes and Diagnostic RevisionsJames Tobin, Ph.D.
DSM-5 represents the field’s most recent attempt at revising the DSM-IV-TR diagnostic nomenclature. In this presentation, I will outline the primary efforts of the DSM-5 Task Force and the major diagnostic changes that were incorporated in the new manual, with an emphasis on the disorders of adulthood. The most promising changes are the organization of mental illness as a spectrum, the addition of dimensionality to specifier descriptions, lifespan/development and cultural refinements, and the articulation of a new hybrid model of mental illness. In the context of these gains, I also will provide a summary of the major controversies surrounding the DSM-5, including misgivings about lower thresholds to qualify for numerous diagnoses and the related concern that we may now run the risk of pathologizing “normal” human functioning.
Core slides from my presentation about the new DSM diagnostic system. The full presentation has more zing but I removed some to streamline and to whet the appetite.
These simplified slides by Dr. Sidra Arshad present an overview of the non-respiratory functions of the respiratory tract.
Learning objectives:
1. Enlist the non-respiratory functions of the respiratory tract
2. Briefly explain how these functions are carried out
3. Discuss the significance of dead space
4. Differentiate between minute ventilation and alveolar ventilation
5. Describe the cough and sneeze reflexes
Study Resources:
1. Chapter 39, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 34, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 17, Human Physiology by Lauralee Sherwood, 9th edition
4. Non-respiratory functions of the lungs https://academic.oup.com/bjaed/article/13/3/98/278874
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists Saeid Safari
Preoperative Management of Patients on GLP-1 Receptor Agonists like Ozempic and Semiglutide
ASA GUIDELINE
NYSORA Guideline
2 Case Reports of Gastric Ultrasound
The Gram stain is a fundamental technique in microbiology used to classify bacteria based on their cell wall structure. It provides a quick and simple method to distinguish between Gram-positive and Gram-negative bacteria, which have different susceptibilities to antibiotics
micro teaching on communication m.sc nursing.pdfAnurag Sharma
Microteaching is a unique model of practice teaching. It is a viable instrument for the. desired change in the teaching behavior or the behavior potential which, in specified types of real. classroom situations, tends to facilitate the achievement of specified types of objectives.
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...Oleg Kshivets
Overall life span (LS) was 1671.7±1721.6 days and cumulative 5YS reached 62.4%, 10 years – 50.4%, 20 years – 44.6%. 94 LCP lived more than 5 years without cancer (LS=2958.6±1723.6 days), 22 – more than 10 years (LS=5571±1841.8 days). 67 LCP died because of LC (LS=471.9±344 days). AT significantly improved 5YS (68% vs. 53.7%) (P=0.028 by log-rank test). Cox modeling displayed that 5YS of LCP significantly depended on: N0-N12, T3-4, blood cell circuit, cell ratio factors (ratio between cancer cells-CC and blood cells subpopulations), LC cell dynamics, recalcification time, heparin tolerance, prothrombin index, protein, AT, procedure type (P=0.000-0.031). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and N0-12 (rank=1), thrombocytes/CC (rank=2), segmented neutrophils/CC (3), eosinophils/CC (4), erythrocytes/CC (5), healthy cells/CC (6), lymphocytes/CC (7), stick neutrophils/CC (8), leucocytes/CC (9), monocytes/CC (10). Correct prediction of 5YS was 100% by neural networks computing (error=0.000; area under ROC curve=1.0).
Adv. biopharm. APPLICATION OF PHARMACOKINETICS : TARGETED DRUG DELIVERY SYSTEMSAkankshaAshtankar
MIP 201T & MPH 202T
ADVANCED BIOPHARMACEUTICS & PHARMACOKINETICS : UNIT 5
APPLICATION OF PHARMACOKINETICS : TARGETED DRUG DELIVERY SYSTEMS By - AKANKSHA ASHTANKAR
Muktapishti is a traditional Ayurvedic preparation made from Shoditha Mukta (Purified Pearl), is believed to help regulate thyroid function and reduce symptoms of hyperthyroidism due to its cooling and balancing properties. Clinical evidence on its efficacy remains limited, necessitating further research to validate its therapeutic benefits.
New Drug Discovery and Development .....NEHA GUPTA
The "New Drug Discovery and Development" process involves the identification, design, testing, and manufacturing of novel pharmaceutical compounds with the aim of introducing new and improved treatments for various medical conditions. This comprehensive endeavor encompasses various stages, including target identification, preclinical studies, clinical trials, regulatory approval, and post-market surveillance. It involves multidisciplinary collaboration among scientists, researchers, clinicians, regulatory experts, and pharmaceutical companies to bring innovative therapies to market and address unmet medical needs.
1. Recent Updates to Proposed Revisions for DSM-5
Below is a list of updates made to this Web site, including changes in draft criteria and other
proposed revisions, since its initial launch in February 2010. Between now and June 15, 2011, we
welcome your comments and questions on these changes. Work group members will review all
comments, and after completion of the DSM-5 Field Trials later this year, a third round of revisions
will be made, followed by a third opportunity to submit feedback. At that time, this page will be
updated to orient visitors to areas of the Web site that have changed.
DSM Changes
• Revised structural organization of diagnostic chapters
• Continual update of DSM-5 Timeline as needed
• Expanded FAQ
• Updated list of DSM-5 research planning conference monographs
• Updated list of DSM-5 journal publications
• Updated list of DSM-5 member presentations
• Addition of a section on DSM-5 Field Trials, including detailed documentation on design, protocols, listing of field trial sites, and the
ability for visitors to register as potential volunteer participants in the routine clinical practice design
• Addition of new press releases as they occur
Disorder-Specific Changes
Adjustment Disorders
Criteria changes:
• Adjustment Disorder – deletion of the bereavement exclusion criterion and addition of a
subtype of “Related to Bereavement”
Anxiety Disorders
Criteria changes:
• Posttraumatic Stress Disorder
• Acute Stress Disorder
• Obsessive Compulsive Disorder
• Hoarding Disorder
• Olfactory Reference Syndrome
• Skin Picking Disorder
• Specific Phobia
• Social Anxiety Disorder (Social Phobia) – minor wording changes and addition of a
subtype of Selective Mutism
• Generalized Anxiety Disorder – 1) change of the proposed name from Generalized
Anxiety and Worry Disorder to Generalized Anxiety Disorder; 2) change of the number
of symptoms in criterion C (i.e., put all 6 symptoms from DSM-IV back to criterion C);
3) some minor wording changes
• Panic Attack
• Agoraphobia
• Panic Disorder
2. Severity scale updates:
• The previously proposed severity scales for Anxiety Disorders have been updated.
Delirium, Dementia, Amnestic, and Other Cognitive Disorders (Neurocognitive Disorders)
Criteria changes:
• Mild Neurocognitive Disorder – now allows “equivalent clinical judgment” where
neuropsych testing is not available or practical, name changed from Minor to Mild, and
minor wording changes to other criteria
• Major Neurocognitive Disorder – now allows “equivalent clinical judgment” where
neuropsych testing is not available or practical and minor wording changes to other
criteria
Post-launch addition of proposed criteria to the following DSM-IV disorders:
• Traumatic Brain Injury Subtype
• Additional subtype criteria are likely to be available by launch in April
Disorders Usually First Diagnosed in Infancy, Childhood, or Adolescence
Addition of the following disorders new to DSM-5:
• Language Impairment
• Late Language Emergence
• Specific Language Impairment
• Social Communication Disorder
• Voice Disorder
• Elimination of the following DSM-IV disorders:
• Expressive Language Disorder
• Mixed Receptive-Expressive Language Disorder
• Communication Disorder Not Otherwise Specified (now diagnosable under Language
Impairment umbrella category)
Post-launch addition of proposed criteria to the following DSM-IV disorders:
• ADHD
• Phonological Disorder (now Speech Sound Disorder)
• Stuttering (now Childhood Onset Fluency Disorder)
Criteria changes:
• Intellectual Disability (soon to be called Intellectual Developmental Disorder) –
removed the requirement for testing to demonstrate adaptive functioning deficit and
removed suggestion that 2 std is the appropriate cut-off for adaptive functioning deficit
based on new data analyses
3. • Autism Spectrum Disorder – reinstated examples in criteria to add clarity and changed
wording in most criteria to add clarity; added severity
• Separation Anxiety Disorder - criteria and severity scale updates
• Stereotypic Movement Disorder- criteria and severity scale updates
• Tourette’s Disorder- criteria and severity scale updates
• Chronic Motor or Vocal Tic Disorder - criteria and severity scale updates
• Provisional Tic Disorder - criteria and severity scale updates
• Tic Disorder Not Otherwise Specified
Dissociative Disorders
Criteria changes:
• Dissociative Amnesia
• Depersonalization /Derealization Disorder
• Dissociative Disorder Not Otherwise Specified
Severity scale updates:
• The severity scales for proposed Dissociative Disorders have been updated.
Eating Disorders
Criteria changes:
• Binge Eating Disorder
• Anorexia Nervosa – reworded criteria for clarity; eliminated requirement for
amenorrhea;
• Bulimia Nervosa – reduced requirement for binge/purge frequency
• Eating Disorder Not Otherwise Specified (being renamed Feeding and Eating
Conditions Not Elsewhere Classified) – added descriptions of several conditions of
potential clinical significance
Impulse-Control Disorders Not Elsewhere Classified
Criteria changes:
• Hair-Pulling Disorder (Trichotillomania) - criteria and severity scale updates
Factitious Disorders
Criteria changes:
• Factitious Disorder
4. Mood Disorders
Addition of the following disorders to DSM-5:
• Premenstrual Dysphoric Disorder
• Mixed Features Specifier
• Mixed Anxiety Depression
• Elimination of the following DSM-IV disorders:
• Mixed Episode (being replaced by Mixed Features Specifier)
• Bipolar I Disorder – Single Manic Episode
• Mood Disorder Not Otherwise Specified
Criteria changes:
• Cyclothymic Disorder
• Bipolar I Disorder – Current or Most Recent Episode Hypomanic
• Bipolar I Disorder – Current or Most Recent Episode Manic
• Bipolar I Disorder – Current or Most Recent Episode Depressed – changed criteria A to
include at least 3 major symptoms of Major Depression of which one of the symptoms is
depressed mood or anhedonia
• Bipolar I Disorder– Current or Most Recent Episode Unspecified
• Bipolar II Disorder – Current or Most Recent Episode Hypomanic – separated from
Bipolar II Disorder – Current or Most Recent Episode Depressed
• Bipolar II Disorder – Current or Most Recent Episode Depressed – separated from
Bipolar II Disorder – Current or most Recent Episode Hypomanic
• Bipolar Disorder Not Otherwise Specified
• Major Depressive Disorder, Single Episode
• Major Depressive Disorder, Recurrent
• Dysthymic Disorder (Chronic Depressive Disorder)
• Depressive Disorder Not Otherwise Specified
Personality Disorders
Criteria changes:
• Schizotypal Personality Disorder
• Antisocial Personality Disorder
• Borderline Personality Disorder
• Avoidant Personality Disorder
5. • Obsessive-Compulsive Personality Disorder
• General Criteria for Personality Disorders
• Levels of Personality Functioning
• Personality Trait Domains
Schizophrenia and Other Psychotic Disorders
Criteria changes:
• Attenuated Psychosis Syndrome
• Catatonia Specifier – changed disorders this specifier applies to
• Schizoaffective Disorder
• Delusional Disorder
• Brief Psychotic Disorder
• Schizophrenia – changed criteria A; removal of reference to Mixed Episode
Sexual and Gender Identity Disorders
Criteria changes:
• Hypersexual Disorder
• Paraphilic Coercive Disorder
• Sexual Interest/Arousal Disorder in Women
• Genito-Pelvic Pain Penetration Disorder
• Sexual Dysfunction Due to a General Medical Condition
• Sexual Aversion Disorder
• Substance-Induced Sexual Dysfunction
• Gender Identity Disorder in Adolescents or Adults (Gender Incongruence [in
Adolescents or Adults])
• Exhibitionism (Exhibitionistic Disorder)
• Fetishism (Fetishistic Disorder)
• Frotteurism (Frotteuristic Disorder)
• Pedophilia (Pedohebephilic Disorder)
• Sexual Masochism (Sexual Masochism Disorder)
• Sexual Sadism (Sexual Sadism Disorder)
• Transvestic Fetishism (Transvestic Disorder)
• Voyeurism (Voyeuristic Disorder)
6. • Paraphilia Not Otherwise Specified (Paraphilic Disorders Not Otherwise Specified)
• Hypoactive Sexual Desire Disorder (renamed Hypoactive Sexual Desire Disorder in
Men) – made exclusive to men
• Male Erective Disorder (renamed to Erectile Disorder)
• Female Orgasmic Disorder
• Male Orgasmic Disorder (renamed to Delayed Ejaculation)
• Premature Ejaculation (renamed Early Ejaculation)
• Sexual Dysfunction Not Otherwise Specified (Sexual Dysfunction Not Elsewhere
Classified)
Sleep Disorders
Criteria changes:
• Restless Leg Syndrome
• Primary Insomnia – changes to capture pediatric or developmental symptoms
Somatoform Disorders
Addition of the following disorders to DSM-5:
• Simple Somatic Symptom Disorder
• Illness Anxiety Disorder
Elimination of the following DSM-IV disorders:
• Hypochondriasis (being replaced by Illness Anxiety Disorder)
Criteria changes:
• Body Dysmorphic Disorder - criteria and severity scale updates
• Complex Somatic Symptom Disorder – multiple changes to criteria and optional
specifiers
• Conversion Disorder (renamed Functional Neurological Symptoms) – addition of
criterion D
Substance-Related Disorders
Addition of new Substance-Induced Disorders criteria pending